Evidence map›Paper›PMID 25599090›Full record

ArticleInternational journal of medical and pharmaceutical case reports2014

EBV-Positive Grey Zone Lymphoma in an HIV Infected Man from Kampala, Uganda: Case Report.

Lynette K Tumwine, Jackson Orem, Leona W Ayers

Open access · diamondAbstract read
In one paragraph

Article in International journal of medical and pharmaceutical case reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Lynette K TumwineDepartment of Pathology, School of Biomedical Sciences, College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda ; Sub-Saharan Africa Lymphoma Consortium (NCI/SSALC), USA.
Jackson OremUganda Cancer Institute, P.O. Box 3955, Kampala, Uganda.
Leona W AyersSub-Saharan Africa Lymphoma Consortium (NCI/SSALC), USA ; Department of Pathology, Ohio State University Wexner Medical Center, 2001 Polaris Parkway, Columbus, OH, USA.
Makerere University · UGThe Ohio State University Wexner Medical Center · USUganda Cancer Institute · UG

Funding

Mid-Region AIDS and Cancer Specimen Resource ConsortiumU01CA066531 · NCI · OHIO STATE UNIVERSITY · PI AYERS, LEONA W · 1995 to 2012
$9.8M
NCI NIH HHS U01 CA066531
6 · The paper itself

Abstract

aimWe describe the clinical, histopathological and immunophenotypic characteristics of an HIV-infected adult man on antiretroviral therapy who presented with an EBV-positive grey zone lymphoma. CASE PRESENTATION: A 56-year-old HIV infected man from Uganda presented with a four month history of progressive abdominal swelling and B-symptoms. He was on highly active antiretroviral therapy (HAART) and cotrimoxazole. He was afebrile (36.9°C), severely wasted (BMI 14.8), and mildly anaemic. On physical examination, he had a 15 by 8 cm mass in the hypogastrium and umbilical region. The total white cell count was 8.3×10 DISCUSSION: The tumour had features intermediate between mediastinal large B cell lymphoma and classical Hodgkin lymphoma.

conclusionWe present a case of EBV-positive grey zone lymphoma in an HIV-infected man on HAART therapy diagnosed and treated in a resource constrained medical setting. The histological features are unusual and represent a low incidence lymphoma that is recognized by mixed features reminiscent of Hodgkin's lymphoma and mediastinal large B-cell lymphoma.

Indexed as

EBVgrey zone lymphomaHIV/AIDSUganda

Identifiers

PMID25599090
PMCPMC4293704
OpenAlexW2229675214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.